NASDAQ: HALO - Halozyme Therapeutics, Inc.

Yield per half year: +13.85%
Dividend yield: 0.00%
Sector: Healthcare

Compare companies

Download the report:

Excel

Word

PDF

	Halozyme Therapeutics, Inc.	Gilead Sciences	Amgen
Capitalization
Price	64.84	107.89	306.86
Price priv.
Number of shares, million	134.2	1258	538
Capitalization, billion	5.71	94.55	140.05
EBITDA, billion	0.4224	7.61	7.9
EV, billion	6.37	119.11	206.55
Profit and loss report
Net profit, billion	0.2816	5.67	6.72
Revenue, billion	0.8293	27.12	28.19
EPS	2.1	4.5	12.49
Balance
Assets, billion	1.73	62.13	97.15
Debt, billion	1.53	24.99	64.61
Balance cost, billion	0.0838	22.75	6.23
Cash, billion	0.1184	6.09	10.94
Coefficients
Dividend yield, %	0	3.69	2.92
Dividend	0	3.87	9.13
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	4.79	67.24	67.83
P/S	6.01	3.7	5.42
P/BV	59.49	4.41	24.53
P/E	17.7	17.69	22.76
Ev/Ebitda	15.07	15.66	26.16
Debt/Ebitda	3.63	3.29	8.18
Efficiency
ROE	336	24.9	107.78
ROA	16.25	9.12	6.91
ROIC	42.26	11.06	17
Ebitda margin	50.94	28.05	28.01
Net margin	33.96	20.89	23.83
Momentum
1 week, price changes	+0.8398 %	+0.3535 %	-2.82 %
1 month, price changes	+10.84 %	-2.83 %	-0.9234 %
3 months, price changes	+36.39 %	+14.84 %	+16.02 %
6 months, price changes	+13.85 %	+29.93 %	-3.84 %
1 year, price changes	+59.19 %	+47.77 %	+7.18 %
3 years, price changes	+48.51 %	+81.82 %	+31.59 %
5 years, price changes	+161.66 %	+80.42 %	+33.46 %
10 years, price changes	+319.68 %	+24.66 %	+101.52 %

More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe